Pfizer Limited — Others, 14-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Pfizer Limited has announced a board meeting to discuss the certificate issued by KFin Technologies for the quarter ended December 31, 2024, confirming compliance with SEBI regulations regarding the dematerialisation of securities. This update indicates that all securities received for dematerialisation were processed appropriately, assuring investors of adherence to regulatory standards. This could enhance investor confidence, reflecting a commitment to operational transparency and efficiency in handling securities. Overall, shareholders may view this announcement positively, as it underscores the company’s proactive governance in maintaining compliance and investor trust.